Literature DB >> 26401188

A mimic of soft tissue infection: intra-arterial injection drug use producing hand swelling and digital ischemia.

Sean D Foster1, Michael S Lyons1, Christopher M Runyan2, Edward J Otten1.   

Abstract

BACKGROUND: Inadvertent intra-arterial injection of illicit substances is a known complication of injection drug use and can lead to severe complications, including infection, ischemia and compartment syndrome. Identifying complications of intra-arterial injection can be difficult, as clinical manifestations overlap with other more common conditions such as cellulitis and soft tissue infection, and a history of injection drug use is frequently not disclosed.
METHODS: A 37-year-old male patient presented with 24 hours of right hand pain, erythema and swelling. Despite classic "track marks", he denied a history of injection drug use, and vascular insults were not initially considered. After failing to respond to three days of aggressive treatment for suspected deep-space infection, an arteriogram demonstrated findings consistent with digital ischemia of embolic etiology.
RESULTS: As a result of the delay in diagnosis, the lesion was not amenable to reperfusion and the patient required amputation of the distal digit.
CONCLUSION: Practitioners should be alert to the possibility of intra-arterial injection and resulting complications when evaluating unusual extremity infections or unexplained ischemic symptoms, even in the absence of a definite history of injection drug use.

Entities:  

Keywords:  Digital ischemia; Injection drug use; Intra-arterial injection; Opioid abuse

Year:  2015        PMID: 26401188      PMCID: PMC4566017          DOI: 10.5847/wjem.j.issn.1920-8642.2015.03.014

Source DB:  PubMed          Journal:  World J Emerg Med        ISSN: 1920-8642


  19 in total

1.  Accidental intra-arterial injection in drug addicts.

Authors:  J C Cooper; A B Griffiths; R B Jones; A T Raftery
Journal:  Eur J Vasc Surg       Date:  1992-07

2.  Illicit drug use and injection practices among drug users on methadone and buprenorphine maintenance treatment in France.

Authors:  Anne Guichard; France Lert; Christine Calderon; Hind Gaigi; Olivier Maguet; Jérôme Soletti; Jean-Marc Brodeur; Lucie Richard; Mike Benigeri; Maria-Victoria Zunzunegui
Journal:  Addiction       Date:  2003-11       Impact factor: 6.526

3.  The emerging buprenorphine epidemic in the United States.

Authors:  Eric D Wish; Erin Artigiani; Amy Billing; Wanda Hauser; Jordana Hemberg; Myron Shiplet; Robert L DuPont
Journal:  J Addict Dis       Date:  2012

Review 4.  Complications after unintentional intra-arterial injection of drugs: risks, outcomes, and management strategies.

Authors:  Surjya Sen; Eduardo Nunes Chini; Michael J Brown
Journal:  Mayo Clin Proc       Date:  2005-06       Impact factor: 7.616

5.  The rising prevalence of prescription opioid injection and its association with hepatitis C incidence among street-drug users.

Authors:  Julie Bruneau; Elise Roy; Nelson Arruda; Geng Zang; Didier Jutras-Aswad
Journal:  Addiction       Date:  2012-03-22       Impact factor: 6.526

6.  Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users.

Authors:  Hannu Alho; David Sinclair; Erkki Vuori; Antti Holopainen
Journal:  Drug Alcohol Depend       Date:  2006-10-19       Impact factor: 4.492

7.  Complications in the upper extremity following intra-arterial drug abuse.

Authors:  N C Lindfors; L Vilpponen; T Raatikainen
Journal:  J Hand Surg Eur Vol       Date:  2010-03-17

8.  Acute hand ischemia after intra-arterial injection of meprobamate powder.

Authors:  Chen-Ken Seak; Xiu-Jin Kooi; Chen-June Seak
Journal:  J Emerg Med       Date:  2012-04-11       Impact factor: 1.484

9.  Intra-arterial injection of temazepam in drug abusers.

Authors:  D M Nott; R Chandrasekar; L Enabi; M Greaney; A Bakran; P L Harris
Journal:  Eur J Vasc Surg       Date:  1993-01

10.  Acute ischemia of the hand following intra-arterial oxymetazoline injection.

Authors:  P C Shukla
Journal:  J Emerg Med       Date:  1995 Jan-Feb       Impact factor: 1.484

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.